StockIntel AIStockIntel AI

Eli Lilly and Company (LLY)

STRONG BUY

AI-powered analysis, Wall Street analyst consensus, and market data for Eli Lilly and Company. Updated automatically — see why LLY is rated Buy today.

$1,413.79

Updated 2h ago

Price

$1,413.79

Day change

-1.25%

Analysts Buy

86%

P/E ratio

65.3

Market cap

$1.35T

LLY price chart

AI analysis for LLY

Eli Lilly's recent uptick, buoyed by promising clinical updates on drugs like Zepbound, shows potential for continued growth in the obesity treatment space, but the hefty P/E ratio of 65.8x indicates the market may be pricing in a lot of optimism already.

Read the full analysis, freeAlready have an account? Sign in

Wall Street analyst ratings

Ask Stoki about LLY

Free with an account. It only takes an email.

Related stocks

More from Consumer & healthcare

Track LLY and 150+ more with StockIntel AI

Daily AI stock analysis, regularly updated ratings, and the Higher-or-Lower game — completely free.

Ratings are derived from Wall Street analyst consensus (via our market data partner) and AI-generated analysis. For informational purposes only — not financial advice. See our full disclaimer.